BRCA2 and ovarian cancer: Serous ovarian cancer is known to feature a high frequency of HR deficiency, often caused by homozygous loss of BRCA1 or BRCA2, either through germline or somatic inactivating mutations, or through promoter methylation, and there are defects in a large number of other DNA repair genes that could affect HR as well [17].